Conducted an organisation Green House Gas (GHG) assessment with the support of Carbon Footprint Ltd to understand the GHG emissions associated with current UK operations.
Developed and updated a clear Carbon Reduction Plan (CRP) which includes a clear path towards net zero through carbon emission target setting.
Begun to assess the carbon footprint of supplied products, allowing us to further develop our CRP.
Completed the NHS Evergreen Sustainable Supplier Assessment which supports our understanding and alignment with NHS sustainability priorities, identifying areas for improvement. We are delighted to be supporting the NHS to achieve their net zero and sustainability ambitions, including those set out in the NHS Net Zero Supplier Roadmap.
Assessed the carbon footprint of our respiratory portfolio and certified all products within this portfolio as carbon neutral.
Initiated work to reformulate products in our pMDI portfolio to incorporate a propellant with near-zero global warming potential (GWP). This initiative, which we expect development work to complete in 2026 and regulatory filing to commence shortly after, aims to provide patients with products that maintain the same efficacy and safety profile, while significantly reducing their environmental impact compared to existing options.
Based on our current Carbon Reduction Plan we project a 70% reduction in tCO2e emissions per £M turnover by 2030a and a 50% reduction in absolute tCO2e emissions by 2036.

Our Carbon Reduction Plan can be viewed here.

Set a target and developed a plan to achieve net zero by 2045

Contact Us